NCT00368394View on ClinicalTrials.gov

Dose-Exposure-Response in Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2004

Conditions
Diabetes Mellitus, Type I
Interventions
DRUG

Insulin glulisine

Trial Locations (1)

Unknown

Sanofi-Aventis, Neuss

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY